Abstract
Electrochemical chip-based sensors (ECCS) have become a standard method in biosensing of small molecules, as well as more complex structures like immunoassays. Numerous research publications highlight the simplicity, cost-efficiency, and point-of-need applicability of disposable ECCS across various applications. However, their societal uptake remains limited. This is primarily due to reproducibility issues during testing in buffer solutions and the high cost of single-use chips. Moreover, multiple measurements can compromise sensor stability and reproducibility. Specifically, label-free electrochemical impedance spectroscopy (EIS)-based ECCS are susceptible to signal drift, which can result in false-positive or false-negative data, thus questioning the reliability of the measurements. In this talk, I will address the challenges faced with electrochemical sensors in the validation process of sensor performance. I will provide examples of how to select the appropriate electrochemical method and sensor surface to achieve robust and reliable results. I will introduce a novel method for the multiple uses of ECCSs. This method involves incubating the ECCSs in nitrogen-purged, deaerated phosphate-buffered saline (N-PBS) to minimize signal drift in repeated or multiple EIS measurements. This method was subsequently employed to develop a peptide-based EIS biosensor for the detection of Vancomycin, a last-line antibiotic used for treating severe multidrug-resistant bacterial infections using an immunoassay approach. Additionally, this method facilitated the detection of small molecules such as cytokinin, which plays a crucial role in plant root interaction with the soil microbiome for enhanced plant growth. These examples illustrate the versatility and efficacy of the method.
Biography
Winnie Edith Svendsen completed her master degree in experimental physics with honors in 1993 from the University College Dublin, within atomic spectroscopy. She received her doctorate in atomic physics studying the properties of solid deuterium by laser ablation and sputtering in 1996 from Copenhagen University, Denmark. Thereafter she accepted a postdoctoral position at the Max Planck Institute for Plasma physics, Garching, Germany. She returned to Denmark in 1998 and was appointed Associate Professor at Copenhagen University in 1999. Since 2001 she has been involved with applied research and her current research focus is on understanding the physical properties of biological material to optimize the use of micro and nanotechnology in the biomedical field. She was also the co-founder of company XeHe Hypol (APS).